Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 21
SponsorInstitut Curie
About this trial
Interest of a Taurolidine lock at each catheter closure in the primary prevention of catheter-related endoluminal infection in paediatric oncology.
Multicentric, controlled, randomized and double-blind label study.
Eligibility criteria
Qualifiers
Patient less than or equal to 21 years of age at inclusion.
Patient for whom a central catheter is planned to be inserted*, excluding a non-tunneled femoral or cervical external catheter or a peripherally inserted central catheter (as PICC line). *1st catheter placement or placement following a relapse (this placement must take place at least one month after previous catheter removal).
Patient treated for a cancer.
Patient with regular follow-up in the inclusion center.
Disqualifiers
Patient with retinoblastoma.
Allografted patient.
Patient with a life expectancy of less than 6 months.
Patient refusing to participate in the protocol.
Trial design
Treatments tested in this trial
- TaurolockTM
- Physiological serum
Treatment groups
148 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov